focuses its investments exclusively within the

healthcare industry. We are actively seeking companies operating in the following segments:
 

	Specialty distribution with a focus on the alternate site (non-hospital) and pharmaceutical niches.
	Provider and payor outsourcing with a focus on contract management, staffing, utilization and disease management, billing, collections and other financial service providers.
	Pharmacy, infusion and home healthcare with a focus on chronic and acute disease pharmacy, hospice, institutional pharmacy and pharmacy benefit management.
	Outpatient and alternate site services with a focus on surgery centers, psychiatric services, dental and physician services, allied professional and diagnostic and laboratory services.
	Medical products manufacturing with a focus on manufacturers of capital equipment, medical and dental instruments, and other niche products.

We seek to structure the following types of transactions:


The majority of our investments are in small to medium sized companies operating in the healthcare services segment. Target segments include specialty distribution, provider and payor outsourcing, pharmacy, drug infusion, outpatient and alternate site healthcare and medical products manufacturing. Target companies will be run by highly capable management teams and will exhibit identifiable competitive advantages and a significant barrier-to-entry, high return on invested capital, and high customer quality and retention rates. Investments of this type will be comprised primarily of leveraged acquisitions of corporate subsidiaries, recapitalizations of founder-owned and operated entities and management-led acquisitions of independent companies. Total enterprise values will range from $10 million to $500 million.


A smaller portion of our investments are in growth-stage companies operating in the healthcare service, medical product and information technology segments. Target companies will be involved in high growth segments that exhibit high user adoption rates, compelling demographic trends, provide for an unmet clinical or service need and reduce costs in the healthcare delivery system. Total enterprise values will range from $5 million to $50 million.